|
AEBP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.531600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.695700E-02 |
| Normal-vs-Stage2 |
3.766800E-01 |
| Normal-vs-Stage3 |
3.317000E-01 |
| Normal-vs-Stage4 |
4.876800E-01 |
| Stage1-vs-Stage2 |
9.662800E-01 |
| Stage1-vs-Stage3 |
4.323500E-02 |
| Stage1-vs-Stage4 |
1.778210E-01 |
| Stage2-vs-Stage3 |
1.781770E-01 |
| Stage2-vs-Stage4 |
2.384000E-01 |
| Stage3-vs-Stage4 |
9.887200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.726000E-01 |
| Normal-vs-AfricanAmerican |
9.666400E-01 |
| Normal-vs-Asian |
6.990200E-01 |
| Caucasian-vs-AfricanAmerican |
4.012600E-01 |
| Caucasian-vs-Asian |
5.202000E-01 |
| AfricanAmerican-vs-Asian |
7.323000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.273570E-01 |
| Normal-vs-Female |
2.523600E-01 |
| Male-vs-Female |
1.496200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.183200E-01 |
| Normal-vs-Extreme_Weight |
1.239350E-01 |
| Normal-vs-Obese |
8.028000E-01 |
| Normal-vs-Extreme_Obese |
1.072820E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.819000E-01 |
| Normal_Weight-vs-Obese |
3.123000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.914200E-01 |
| Extreme_Weight-vs-Obese |
1.467590E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.042000E-01 |
| Obese-vs-Extreme_Obese |
1.766840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.115600E-02 |
| Normal-vs-Age(41-60Yrs) |
5.714400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.373900E-02 |
| Normal-vs-Age(81-100Yrs) |
1.417820E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.385610E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.336000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.146140E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.175580E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.420830E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.911400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.246200E-01 |
| Normal-VS-Type2 PRCC |
6.171600E-02 |
| Normal-VS-KIRP CIMP |
4.551800E-01 |
| Normal-VS-Unclassified PRCC |
4.239200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.570250E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.668000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.083200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.059250E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.530000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.700400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.429600E-01 |
| Normal-vs-N1 |
1.049950E-01 |
| Normal-vs-N2 |
2.205400E-01 |
| N0-vs-N1 |
1.158240E-02 |
| N0-vs-N2 |
6.332100E-02 |
| N1-vs-N2 |
7.324600E-01 |
|
|
